Edition:
United Kingdom

Novo Nordisk A/S (NOVOb.CO)

NOVOb.CO on Copenhagen Stock Exchange

273.30DKK
21 Jul 2017
Change (% chg)

kr.-4.80 (-1.73%)
Prev Close
kr.278.10
Open
kr.278.20
Day's High
kr.279.30
Day's Low
kr.271.00
Volume
2,497,353
Avg. Vol
3,509,425
52-wk High
kr.384.80
52-wk Low
kr.218.20

NOVOb.CO

Chart for NOVOb.CO

About

Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity... (more)

Overall

Beta: 1.48
Market Cap(Mil.): kr.536,368.81
Shares Outstanding(Mil.): 1,962.56
Dividend: 4.60
Yield (%): 2.78

Financials

  NOVOb.CO Industry Sector
P/E (TTM): 17.85 13.56 17.15
EPS (TTM): 15.31 -- --
ROI: 89.20 -7.26 -5.60
ROE: 99.57 -6.80 -4.89

BRIEF-Novo Holdings reports 12.03 pct stake in HTG Molecular Diagnostics as on July 3

* Novo Holdings A/S reports 12.03 percent stake in HTG Molecular Diagnostics Inc as on July 3, 2017 - sec filing‍​

20 Jul 2017

BRIEF-Innate Pharma issues 3,343,748 ordinary shares

* REG-ISSUANCE BY INNATE PHARMA OF 3,343,748 ORDINARY SHARES TO NOVO NORDISK A/S IN CONSIDERATION FOR RIGHTS IN ANTI-C5AR

13 Jul 2017

Novo Nordisk recalls faulty cartridge holders in insulin pens

Danish drugmaker Novo Nordisk said on Wednesday it was initiating a recall of insulin cartridge holders used in some NovoPen Echo insulin pen devices distributed in the United States because the holders may crack or break if exposed to certain chemicals, including certain cleaning agents.

05 Jul 2017

UPDATE 1-Novo Nordisk recalls faulty cartridge holders in insulin pens

July 5 Danish drugmaker Novo Nordisk said on Wednesday it was initiating a recall of insulin cartridge holders used in some NovoPen Echo insulin pen devices distributed in the United States because the holders may crack or break if exposed to certain chemicals, including certain cleaning agents.

05 Jul 2017

BRIEF-Novo Nordisk recalls cartridge holders in certain NovoPen Echo insulin delivery devices

* Novo Nordisk recalls cartridge holders in certain NovoPen Echo insulin delivery devices due to potential health risks

05 Jul 2017

Novo Nordisk warns of faulty insulin pens in Canada

July 5 Danish drugmaker Novo Nordisk warned on Wednesday that the insulin cartridge holder in some of its insulin pen devices might crack or break if exposed to certain chemicals, including some cleaning agents.

05 Jul 2017

Novo Nordisk says obesity drug helps up to 13.8 percent weight loss in phase 2 trial

COPENHAGEN Danish drugmaker Novo Nordisk said on Friday a phase 2 trial for its big hope in tackling obesity, an improved GLP-1 drug called semaglutide, showed a weight loss of up to 13.8 percent in people with severe conditions.

23 Jun 2017

Novo Nordisk says obesity drug helps up to 13.8 pct weight loss in phase 2 trial

COPENHAGEN, June 23 Danish drugmaker Novo Nordisk said on Friday a phase 2 trial for its big hope in tackling obesity, an improved GLP-1 drug called semaglutide, showed a weight loss of up to 13.8 percent in people with severe conditions.

23 Jun 2017

CORRECTED-BRIEF-Novo Nordisk submits EU application for Tresiba label update

* Submits application in the EU for including data from the DEVOTE trial in the Tresiba label Source text for Eikon: Further company coverage: (Reporting by Stine Jacobsen)

14 Jun 2017

BRIEF-Novo Nordisk says Tresiba showed significant reduction in rates of severe hypoglycaemia compared to insulin glargine

* tresiba showed no increased risk of major cardiovascular events and significant reduction in rates of severe hypoglycaemia compared to insulin glargine

12 Jun 2017

Earnings vs. Estimates